1. Home
  2. DTI vs CRDL Comparison

DTI vs CRDL Comparison

Compare DTI & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Drilling Tools International Corporation

DTI

Drilling Tools International Corporation

HOLD

Current Price

$2.65

Market Cap

76.7M

Sector

Industrials

ML Signal

HOLD

Logo Cardiol Therapeutics Inc.

CRDL

Cardiol Therapeutics Inc.

HOLD

Current Price

$1.07

Market Cap

97.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DTI
CRDL
Founded
1984
2017
Country
United States
Canada
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
76.7M
97.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DTI
CRDL
Price
$2.65
$1.07
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$9.00
AVG Volume (30 Days)
112.5K
686.1K
Earning Date
11-06-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$160,964,000.00
N/A
Revenue This Year
$2.91
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7.46
N/A
52 Week Low
$1.43
$0.77
52 Week High
$3.82
$1.59

Technical Indicators

Market Signals
Indicator
DTI
CRDL
Relative Strength Index (RSI) 53.51 55.68
Support Level $2.39 $0.88
Resistance Level $3.15 $1.12
Average True Range (ATR) 0.26 0.08
MACD 0.03 0.02
Stochastic Oscillator 50.51 83.33

Price Performance

Historical Comparison
DTI
CRDL

About DTI Drilling Tools International Corporation

Drilling Tools International Corp manufactures, rents, inspects, and refurbishes downhole drilling tools primarily to companies in the oil and natural gas industry for bottom hole assemblies used in onshore and offshore horizontal and directional drilling. The company's United States operations have locations in Texas, California, Louisiana, Oklahoma, Pennsylvania, North Dakota, New Mexico, Utah, and Wyoming. The company's single segment derives revenues from customers by providing oilfield equipment and services to operators in the oil and natural gas sectors.

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

Share on Social Networks: